Key result
A smartphone-based walking distance test demonstrated high reliability compared to in-clinic ground truth measurements, with a Cronbach's alpha of 0.99 for in-clinic and 0.74 for at-home testing.
Why the study?
The 6-min walk test is a validated proxy for frailty and predictor of clinical outcomes, but implementation challenges limit its widespread use.
Does a smartphone-based at-home 6-min walk test provide reliable measurements compared to in-clinic 6MWT in patients scheduled for cardiac or vascular surgery?
Observational (n=110)
No
Does a smartphone-based at-home 6-min walk test provide reliable measurements compared to in-clinic 6MWT in patients scheduled for cardiac or vascular surgery?
Answers are grounded in this paper and cite their sources.
A smartphone-based 6-minute walk test demonstrates high reliability compared to in-clinic measurements, offering a feasible at-home functional assessment for cardiovascular patients.
Aims: The 6-min-walk test (6MWT) is a validated proxy for frailty and a predictor of clinical outcomes, yet is not widely used due to implementation challenges. This comparative effectiveness study assesses the reliability and repeatability of a home-based 6MWT compared to in-clinic 6MWTs in patients with cardiovascular disease. Methods and results: One hundred and ten (110) patients scheduled for cardiac or vascular surgery were enrolled during a study period from June 2018 to December 2019 at the Palo Alto VA Hospital. Subjects were provided with an Apple iPhone 7 and Apple Watch Series 3 loaded with the VascTrac research study application and performed a supervised in-clinic 6MWT during enrolment, at 2 weeks, 1, 3, and 6 months post-operatively. Subjects also received notifications to perform at-home smartphone-based 6MWTs once a week for a duration of 6 months. Test-retest reliability of in-clinic measurements and at-home measurements was assessed with an industry standard Cronbach's alpha reliability test. Test-retest reliability for in-clinic ground truth 6MWT steps vs. in-clinic iPhone 6MWT steps was 0·99, showing high reliability between the two tested measurements. When comparing for in-clinic ground truth 6MWT steps vs. neighbouring at-home iPhone 6MWT steps, reliability was 0·74. Conclusion: Running the test-reliability test on both measurements shows that an iPhone 6MWT test is reliable compared to an in-clinic ground truth measurement in patients with cardiovascular disease.
No takes yet. Share an insight, caveat, or question.
Mak et al. (2021) conducted an observational in Cardiovascular disease (n=110). Smartphone-based 6-min walk test (iPhone and Apple Watch) vs. In-clinic ground truth 6-min walk test was evaluated on Test-retest reliability (Cronbach's alpha) of 6MWT steps (Cronbach's alpha 0.99 (in-clinic) and 0.74 (at-home)). A smartphone-based walking distance test demonstrated high reliability compared to in-clinic ground truth measurements, with a Cronbach's alpha of 0.99 for in-clinic and 0.74 for at-home testing.
Synapse has enriched 10 related papers. Consider them for comparative context: